{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:57:15Z","timestamp":1793246235785,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["440911\/2016-8"],"award-info":[{"award-number":["440911\/2016-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["02797-16"],"award-info":[{"award-number":["02797-16"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The worldwide epidemics of diseases as dengue and Zika have triggered an intense effort to repurpose drugs and search for novel antivirals to treat patients as no approved drugs for these diseases are currently available. Our aim was to screen plant-derived extracts to identify and isolate compounds with antiviral properties against dengue virus (DENV) and Zika virus (ZIKV).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seven thousand plant extracts were screened in vitro for their antiviral properties against DENV-2 and ZIKV by their viral cytopathic effect reduction followed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method, previously validated for this purpose. Selected extracts were submitted to bioactivity-guided fractionation using high- and ultrahigh-pressure liquid chromatography. In parallel, high-resolution mass spectrometric data (MSn) were collected from each fraction, allowing compounds into the active fractions to be tracked in subsequent fractionation procedures. The virucidal activity of extracts and compounds was assessed by using the plaque reduction assay. EC<jats:sub>50<\/jats:sub> and CC<jats:sub>50<\/jats:sub> were determined by dose response experiments, and the ratio (EC<jats:sub>50<\/jats:sub>\/CC<jats:sub>50<\/jats:sub>) was used as a selectivity index (SI) to measure the antiviral <jats:italic>vs.<\/jats:italic> cytotoxic activity. Purified compounds were used in nuclear magnetic resonance spectroscopy to identify their chemical structures. Two compounds were associated in different proportions and submitted to bioassays against both viruses to investigate possible synergy. In silico prediction of the pharmacokinetic and toxicity (ADMET) properties of the antiviral compounds were calculated using the pkCSM platform.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We detected antiviral activity against DENV-2 and ZIKV in 21 extracts obtained from 15 plant species. <jats:italic>Hippeastrum<\/jats:italic> (Amaryllidaceae) was the most represented genus, affording seven active extracts. Bioactivity-guided fractionation of several extracts led to the purification of lycorine, pretazettine, narciclasine, and narciclasine-4-O-\u03b2-D-xylopyranoside (NXP). Another 16 compounds were identified in active fractions. Association of lycorine and pretazettine did not improve their antiviral activity against DENV-2 and neither to ZIKV. ADMET prediction suggested that these four compounds may have a good metabolism and no mutagenic toxicity. Predicted oral absorption, distribution, and excretion parameters of lycorine and pretazettine indicate them as candidates to be tested in animal models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results showed that plant extracts, especially those from the <jats:italic>Hippeastrum<\/jats:italic> genus, can be a valuable source of antiviral compounds against ZIKV and DENV-2. The majority of compounds identified have never been previously described for their activity against ZIKV and other viruses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-022-01751-z","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T11:03:19Z","timestamp":1645527799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Searching for plant-derived antivirals against dengue virus and Zika virus"],"prefix":"10.1186","volume":"19","author":[{"given":"Emerson","family":"de Castro Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia Maria Almeida","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kohlhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya Torres Gaze","family":"Jangola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Eduardo Valente","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina Can\u00e7ado","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rica Alessandra Rocha","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Calzavara-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Sobral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erna Geessien","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Leomar","family":"Zani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0487-8748","authenticated-orcid":false,"given":"Jaquelline Germano","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"1751_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.antiviral.2017.06.001","volume":"144","author":"MT Aliota","year":"2017","unstructured":"Aliota MT, et al. Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network. Antiviral Res. 2017;144:223\u201346. https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.001.","journal-title":"Antiviral Res"},{"issue":"10107","key":"1751_CR2","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/s0140-6736(17)31450-2","volume":"390","author":"D Baud","year":"2017","unstructured":"Baud D, et al. An update on Zika virus infection. Lancet. 2017;390(10107):2099\u2013109. https:\/\/doi.org\/10.1016\/s0140-6736(17)31450-2.","journal-title":"Lancet"},{"issue":"16","key":"1751_CR3","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1056\/NEJMc1609015","volume":"375","author":"T Dos Santos","year":"2016","unstructured":"Dos Santos T, et al. Zika virus and the Guillain-Barre syndrome - case series from seven countries. N Engl J Med. 2016;375(16):1598\u2013601. https:\/\/doi.org\/10.1056\/NEJMc1609015.","journal-title":"N Engl J Med"},{"key":"1751_CR4","unstructured":"FDA. Zika Virus Response Updates from FDA|FDA. Available online: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-issues\/zika-virus-response-updates-fda Accessed on 03 March 2021."},{"key":"1751_CR5","unstructured":"WHO. Dengue and Severe Dengue. Available online: https:\/\/www.who.int\/health-topics\/dengue-and-severe-dengue#tab=tab_1 Accessed on 03 March 2021."},{"issue":"10","key":"1751_CR6","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1080\/21645515.2019.1658503","volume":"15","author":"SJ Thomas","year":"2019","unstructured":"Thomas SJ, Yoon IK. A Review of Dengvaxia\u00ae: development to deployment. Hum Vaccine Immunother. 2019;15(10):2295\u2013314. https:\/\/doi.org\/10.1080\/21645515.2019.1658503.","journal-title":"Hum Vaccine Immunother"},{"issue":"3","key":"1751_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijid.2006.02.012","volume":"11","author":"A Ong","year":"2007","unstructured":"Ong A, et al. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int Infect Dis. 2007;11(3):263\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2006.02.012.","journal-title":"Int Infect Dis"},{"key":"1751_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fcimb.2017.00317","volume":"7","author":"C Guo","year":"2017","unstructured":"Guo C, et al. Global epidemiology of dengue outbreaks in 1990\u20132015: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2017;7:317. https:\/\/doi.org\/10.3389\/fcimb.2017.00317.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"1751_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/CMR.00072-15","volume":"29","author":"D Musso","year":"2016","unstructured":"Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev. 2016;29(3):487\u2013524. https:\/\/doi.org\/10.1128\/CMR.00072-15.","journal-title":"Clin Microbiol Rev"},{"key":"1751_CR10","unstructured":"CDC. Treatment Zika Virus CDC. Available online: https:\/\/www.cdc.gov\/zika\/symptoms\/treatment.html Accessed on 3 Mar 2021."},{"issue":"3","key":"1751_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/ph12030101","volume":"12","author":"M Baz","year":"2019","unstructured":"Baz M, Boivin G. Antiviral agents in development for Zika virus infections. Pharmaceuticals (Basel, Switzerland). 2019;12(3):101. https:\/\/doi.org\/10.3390\/ph12030101.","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"1751_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","volume":"20","author":"NJ Barrows","year":"2016","unstructured":"Barrows NJ, et al. A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe. 2016;20:259\u201370. https:\/\/doi.org\/10.1016\/j.chom.2016.07.004.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"1751_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrd.2017.33","volume":"16","author":"V Boldescu","year":"2017","unstructured":"Boldescu V, et al. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Nat Rev Drug Discov. 2017;16(8):565\u201386. https:\/\/doi.org\/10.1038\/nrd.2017.33.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"1751_CR14","doi-asserted-by":"publisher","first-page":"e00411","DOI":"10.1128\/AAC.00411-17","volume":"61","author":"JC Saiz","year":"2017","unstructured":"Saiz JC, Mart\u00edn-Acebes MA. The race to find antivirals for Zika virus. Antimicrob Agents Chemother. 2017;61(6):e00411\u20137. https:\/\/doi.org\/10.1128\/AAC.00411-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1751_CR15","first-page":"23","volume":"13","author":"AH Teixeira","year":"2014","unstructured":"Teixeira AH, et al. Conhecimento popular sobre o uso de plantas medicinais no munic\u00edpio de Sobral-Cear\u00e1, Brasil. SANARE. 2014;13(1):23\u20138.","journal-title":"SANARE"},{"issue":"8","key":"1751_CR16","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","volume":"33","author":"AG Atanasov","year":"2015","unstructured":"Atanasov AG, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 2015;33(8):1582\u2013614. https:\/\/doi.org\/10.1016\/j.biotechadv.2015.08.001.","journal-title":"Biotechnol Adv"},{"issue":"20","key":"1751_CR17","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1021\/acs.jmedchem.6b00473","volume":"59","author":"BL DeCorte","year":"2016","unstructured":"DeCorte BL. Underexplored opportunities for natural products in drug discovery. J Med Chem. 2016;59(20):9295\u2013304. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00473.","journal-title":"J Med Chem"},{"issue":"3","key":"1751_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"J Chaudhuri","year":"2018","unstructured":"Chaudhuri J. The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metab. 2018;28(3):337\u201352. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.014.","journal-title":"Cell Metab"},{"key":"1751_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod. 2020;83:770\u2013803. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01285.","journal-title":"J Nat Prod"},{"issue":"9","key":"1751_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ptr.1907","volume":"20","author":"EA Palombo","year":"2006","unstructured":"Palombo EA. Phytochemicals from traditional medicinal plants used in the treatment of diarrhoea: modes of action and effects on intestinal function. Phytother Res. 2006;20(9):717\u201324. https:\/\/doi.org\/10.1002\/ptr.1907.","journal-title":"Phytother Res"},{"issue":"1\u20132","key":"1751_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4.","journal-title":"J Immunol Methods"},{"issue":"4","key":"1751_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1590\/s0074-02761999000400019","volume":"94","author":"L Betancur-Galvis","year":"1999","unstructured":"Betancur-Galvis L, et al. Antitumor and antiviral activity of Colombian medicinal plant extracts. Mem Inst Oswaldo Cruz. 1999;94(4):531\u20135. https:\/\/doi.org\/10.1590\/s0074-02761999000400019.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1751_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0378-8741(99)00049-5","volume":"68","author":"AC Kudi","year":"1999","unstructured":"Kudi AC, Myint MS. Antiviral activity of some Nigerian medicinal plant extracts. J Ethnopharmocol. 1999;68:289\u201394. https:\/\/doi.org\/10.1016\/S0378-8741(99)00049-5.","journal-title":"J Ethnopharmocol"},{"key":"1751_CR24","unstructured":"Iversen PW, Beck B, Chen YF, et al., HTS Assay Validation. 2012 May In: Markossian S, Grossman A, Brimacombe K, et al., editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83783\/"},{"key":"1751_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1101\/sqb.1953.018.01.039","volume":"18","author":"R Dulbecco","year":"1953","unstructured":"Dulbecco R, Vogt M. Some problems of animal virology as studied by the plaque technique. Cold Spring Harb Symp Quant Biol. 1953;18:273\u20139. https:\/\/doi.org\/10.1101\/sqb.1953.018.01.039.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"5","key":"1751_CR26","doi-asserted-by":"publisher","first-page":"174837","DOI":"10.1100\/2012\/174837","volume":"1","author":"P Faral-Tello","year":"2012","unstructured":"Faral-Tello P, et al. Cytotoxic, virucidal, and antiviral activity of South American plant and algae extracts. Sci World J. 2012;1(5):174837\u201342. https:\/\/doi.org\/10.1100\/2012\/174837.","journal-title":"Sci World J"},{"issue":"214","key":"1751_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6882-12-214","volume":"12","author":"K Zandi","year":"2012","unstructured":"Zandi K, et al. Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med. 2012;12(214):1\u20139. https:\/\/doi.org\/10.1186\/1472-6882-12-214.","journal-title":"BMC Complement Altern Med"},{"issue":"7","key":"1751_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/jms.1777","volume":"45","author":"H Horai","year":"2010","unstructured":"Horai H, et al. Massbank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom. 2010;45(7):703\u201314. https:\/\/doi.org\/10.1002\/jms.1777.","journal-title":"J Mass Spectrom"},{"issue":"6","key":"1751_CR29","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1021\/acs.analchem.5b04804","volume":"88","author":"PM Allard","year":"2016","unstructured":"Allard PM, et al. Integration of molecular networking and in-silico Ms\/Ms fragmentation for natural products dereplication. Anal Chem. 2016;88(6):3317\u201323. https:\/\/doi.org\/10.1021\/acs.analchem.5b04804.","journal-title":"Anal Chem"},{"issue":"7","key":"1751_CR30","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/cmdc.201300505","volume":"9","author":"P Wang","year":"2014","unstructured":"Wang P, et al. Anti-dengue virus activity and structure-activity relationship studies of lycorine derivatives. ChemMedChem. 2014;9(7):1522\u201333. https:\/\/doi.org\/10.1002\/cmdc.201300505.","journal-title":"ChemMedChem"},{"issue":"11","key":"1751_CR31","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102","volume":"48","author":"QL Fivelman","year":"2004","unstructured":"Fivelman QL, Adagu IS, Warhurst DC. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother. 2004;48(11):4097\u2013102. https:\/\/doi.org\/10.1128\/AAC.48.11.4097-4102.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1751_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","volume":"50","author":"K Seifert","year":"2006","unstructured":"Seifert K, Croft SL. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrob Agents Chemother. 2006;50(1):73\u20139. https:\/\/doi.org\/10.1128\/AAC.50.1.73-79.2006.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1751_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52(1):1. https:\/\/doi.org\/10.1093\/jac\/dkg301.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1751_CR34","first-page":"865","volume":"298","author":"RJ Tallarida","year":"2001","unstructured":"Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther. 2001;298(3):865\u201372.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1751_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1124\/jpet.112.193474","volume":"342","author":"RJ Tallarida","year":"2012","unstructured":"Tallarida RJ. Revisiting the isobole and related quantitative methods for assessing drug synergism. J Pharm Exp Ther. 2012;342(1):2\u20138. https:\/\/doi.org\/10.1124\/jpet.112.193474.","journal-title":"J Pharm Exp Ther"},{"issue":"9","key":"1751_CR36","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066\u201372. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104.","journal-title":"J Med Chem"},{"key":"1751_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-S4-S12","author":"DEV Pires","year":"2011","unstructured":"Pires DEV, et al. Cutoff Scanning Matrix (CSM): structural classification and function prediction by protein inter-residue distance patterns. BMC Genomics. 2011. https:\/\/doi.org\/10.1186\/1471-2164-12-S4-S12.","journal-title":"BMC Genomics"},{"issue":"7","key":"1751_CR38","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/bioinformatics\/btt058","volume":"29","author":"DEV Pires","year":"2013","unstructured":"Pires DEV, et al. aCSM: noise-free graph-based signatures to large-scale receptor-based ligand prediction. Bioinformatics. 2013;29(7):855\u201361. https:\/\/doi.org\/10.1093\/bioinformatics\/btt058.","journal-title":"Bioinformatics"},{"issue":"7","key":"1751_CR39","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1021\/acs.jcim.0c00362","volume":"60","author":"DEV Pires","year":"2020","unstructured":"Pires DEV, Ascher DB. mycoCSM: using graph-based signatures to identify safe potent hits against Mycobacteria. J Chem Inf Model. 2020;60(7):3450\u20136. https:\/\/doi.org\/10.1021\/acs.jcim.0c00362.","journal-title":"J Chem Inf Model"},{"key":"1751_CR40","unstructured":"Moraes CT. Estudo fitoqu\u00edmico das a\u00e9reas de Worsleya procesra (Lem.) Traub (Amaryllidaceae). 2016. Disserta\u00e7\u00e3o (Mestrado em Qu\u00edmica) Centro de Ci\u00eancias Exatas da Universidade Federal do Esp\u00edrito Santo, Esp\u00edrito Santo. https:\/\/repositorio.ufes.br\/bitstream\/10\/7319\/1\/tese_10338_Disserta%C3%A7%C3%A3o%20FINAL%20Carolina%20PDF%20%281%29.pdf"},{"issue":"2","key":"1751_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/14786419.2018.1527836","volume":"34","author":"D Katoch","year":"2019","unstructured":"Katoch D. Narciclasine-4-O-\u03b2-D-xylopyranoside, a new narciclasine glycoside from Zephyranthes minuta. Nat Prod Res. 2019;34(2):233\u201340. https:\/\/doi.org\/10.1080\/14786419.2018.1527836.","journal-title":"Nat Prod Res"},{"issue":"6\u20137","key":"1751_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1078\/094471103322331467","volume":"10","author":"A Schuhmacher","year":"2003","unstructured":"Schuhmacher A, Reichling J, Schnitzler P. Virucidal effect of peppermint oil on the enveloped viruses Herpes simplex virus type 1 and type 2 in vitro. Phytomedicine. 2003;10(6\u20137):504\u201310. https:\/\/doi.org\/10.1078\/094471103322331467.","journal-title":"Phytomedicine"},{"issue":"1","key":"1751_CR43","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.bbrc.2009.11.172","volume":"391","author":"F Gao","year":"2010","unstructured":"Gao F, et al. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry. Biochem Biophys Res Commun. 2010;391(1):952\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.172.","journal-title":"Biochem Biophys Res Commun"},{"issue":"48","key":"1751_CR44","doi-asserted-by":"publisher","first-page":"40525","DOI":"10.1074\/jbc.M112.384446","volume":"287","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, et al. The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation. J Biol Chem. 2012;287(48):40525\u201334. https:\/\/doi.org\/10.1074\/jbc.M112.384446.","journal-title":"J Biol Chem"},{"key":"1751_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11427-020-1818-4","volume":"14","author":"M Guo","year":"2020","unstructured":"Guo M, et al. ZIKV viral proteins and their roles in virus-host interactions. Sci China Life Sci. 2020;14:1\u201311. https:\/\/doi.org\/10.1007\/s11427-020-1818-4.","journal-title":"Sci China Life Sci"},{"key":"1751_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.virol.2020.04.009","volume":"546","author":"H Chen","year":"2020","unstructured":"Chen H, et al. Antiviral activity of lycorine against Zika virus in vivo and in vitro. Virology. 2020;546:88\u201397. https:\/\/doi.org\/10.1016\/j.virol.2020.04.009.","journal-title":"Virology"},{"issue":"3","key":"1751_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.antiviral.2007.12.009","volume":"77","author":"YC Hwang","year":"2008","unstructured":"Hwang YC, et al. Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay. Antiviral Res. 2008;77(3):232\u20136. https:\/\/doi.org\/10.1016\/j.antiviral.2007.12.009.","journal-title":"Antiviral Res"},{"issue":"1","key":"1751_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","volume":"67","author":"S Li","year":"2005","unstructured":"Li S, et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67(1):18\u201323. https:\/\/doi.org\/10.1016\/j.antiviral.2005.02.007.","journal-title":"Antiviral Res"},{"key":"1751_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0923-2516(89)80089-5","volume":"140","author":"J Renard-Nozaki","year":"1989","unstructured":"Renard-Nozaki J, et al. effect of alkaloids isolated from Amaryllidaceae on Herpes simplex virus. Res Virol. 1989;140:115\u201328. https:\/\/doi.org\/10.1016\/s0923-2516(89)80089-5.","journal-title":"Res Virol"},{"issue":"11","key":"1751_CR50","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1021\/np50089a003","volume":"55","author":"B Gabrielsen","year":"1992","unstructured":"Gabrielsen B, et al. Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J Nat Prod. 1992;55(11):1569\u201381. https:\/\/doi.org\/10.1021\/np50089a003.","journal-title":"J Nat Prod"},{"issue":"13","key":"1751_CR51","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1016\/j.bmc.2010.05.023","volume":"18","author":"JC Cedr\u00f3n","year":"2010","unstructured":"Cedr\u00f3n JC, et al. Synthesis and antiplasmodial activity of lycorine derivatives. Bioorg Med Chem. 2010;18(13):4694\u2013701. https:\/\/doi.org\/10.1016\/j.bmc.2010.05.023.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"1751_CR52","doi-asserted-by":"publisher","first-page":"14972","DOI":"10.1038\/srep14972","volume":"5","author":"D Chen","year":"2015","unstructured":"Chen D, et al. Design, synthesis and structure-activity relationship optimization of lycorine derivatives for HCV inhibition. Sci Rep. 2015;5(1):14972. https:\/\/doi.org\/10.1038\/srep14972.","journal-title":"Sci Rep"},{"issue":"2","key":"1751_CR53","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1128\/aac.02274-15","volume":"60","author":"Y Guo","year":"2015","unstructured":"Guo Y, et al. A conserved inhibitory mechanism of a lycorine derivative against enterovirus and Hepatitis C virus. Antimicrob Agents Chemother. 2015;60(2):913\u201324. https:\/\/doi.org\/10.1128\/aac.02274-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1751_CR54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1248\/cpb.24.336","volume":"24","author":"E Furusawa","year":"1976","unstructured":"Furusawa E. Isolation of pretazettine from Narciussus tazetta L. Chem Pharm Bull. 1976;24(2):336\u20138. https:\/\/doi.org\/10.1248\/cpb.24.336.","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"1751_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-291x(73)90957-1","volume":"52","author":"TS Papas","year":"1973","unstructured":"Papas TS, et al. Inhibition of DNA polymerase of avian myeloblastosis virus by an alkaloid extract from Narcissus tazetta L. Biochem Biophys Res Commun. 1973;52(1):88\u201392. https:\/\/doi.org\/10.1016\/0006-291x(73)90957-1.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1751_CR56","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3181\/00379727-145-37892","volume":"145","author":"N Suzuki","year":"1974","unstructured":"Suzuki N, et al. Therapeutic activity of Narcissus alkaloids on Rauscher leukemia: antiviral effect in vitro and rational drug combination in vivo. Proc Soc Exp Biol Med. 1974;145(3):771\u20137. https:\/\/doi.org\/10.3181\/00379727-145-37892.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"1751_CR57","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0005-2787(76)90261-6","volume":"425","author":"A Jimenez","year":"1976","unstructured":"Jimenez A, et al. Inhibitors of protein synthesis in eukaryotic cells: comparative effects of some Amaryllidaceae alkaloids. Biochim Biophys Acta. 1976;425(3):342\u20138. https:\/\/doi.org\/10.1016\/0005-2787(76)90261-6.","journal-title":"Biochim Biophys Acta"},{"key":"1751_CR58","first-page":"251","volume-title":"The alkaloids: chemistry and pharmacology","author":"SF Martin","year":"1987","unstructured":"Martin SF. The Amaryllidaceae alkaloids. Chapter 3. In: Brossi A, editor. The alkaloids: chemistry and pharmacology, vol. 30. New York: Academic Press; 1987. p. 251\u2013376."},{"issue":"4","key":"1751_CR59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000237790","volume":"24","author":"E Furusawa","year":"1978","unstructured":"Furusawa E, et al. Therapeutic activity of pretazettine on Rauscher leukemia: combination of antiviral activity and cellular protein inhibition. Chemotherapy. 1978;24(4):259\u201366. https:\/\/doi.org\/10.1159\/000237790.","journal-title":"Chemotherapy"},{"issue":"1","key":"1751_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000237881","volume":"26","author":"E Furusawa","year":"1980","unstructured":"Furusawa E, et al. Therapeutic activity of pretazettine on Rauscher leukemia: comparison with the related Amaryllidaceae alkaloids. Chemotherapy. 1980;26(1):36\u201345. https:\/\/doi.org\/10.1159\/000237881.","journal-title":"Chemotherapy"},{"issue":"3","key":"1751_CR61","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2165\/00003495-200262030-00009","volume":"62","author":"LJ Scott","year":"2002","unstructured":"Scott LJ, Perry CM. Interferon-alpha-2b plus ribavirin. Drugs. 2002;62(3):507\u201356. https:\/\/doi.org\/10.2165\/00003495-200262030-00009.","journal-title":"Drugs"},{"key":"1751_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-56","author":"SY Whegang","year":"2010","unstructured":"Whegang SY, Tahar R, Foumane VN, et al. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Malaria J. 2010. https:\/\/doi.org\/10.1186\/1475-2875-9-56.","journal-title":"Malaria J"},{"key":"1751_CR63","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1038\/s41598-017-05453-3","volume":"7","author":"J Costa-Gouveia","year":"2017","unstructured":"Costa-Gouveia J, et al. Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. Sci Rep. 2017;7:5390. https:\/\/doi.org\/10.1038\/s41598-017-05453-3.","journal-title":"Sci Rep"},{"issue":"1","key":"1751_CR64","doi-asserted-by":"publisher","first-page":"e0006988","DOI":"10.1371\/journal.pntd.0006988","volume":"13","author":"E Diro","year":"2019","unstructured":"Diro E, et al. A randomized trial of Am Bisome monotherapy and Am Bisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia. PLOS Negl Trop Dis. 2019;13(1):e0006988. https:\/\/doi.org\/10.1371\/journal.pntd.0006988.","journal-title":"PLOS Negl Trop Dis"},{"key":"1751_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijpddr.2019.08.002","volume":"10","author":"LF Gon\u00e7alves-Oliveira","year":"2019","unstructured":"Gon\u00e7alves-Oliveira LF, et al. The combination therapy of meglumine antimoniate and oxiranes (epoxy-\u03b1-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis. Int J Parasitol Drugs Drug Resist. 2019;10:101\u20138. https:\/\/doi.org\/10.1016\/j.ijpddr.2019.08.002.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1751_CR66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/hiv.12716","volume":"4","author":"S Moreno","year":"2019","unstructured":"Moreno S, et al. Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch? HIV Med. 2019;4:2\u201312. https:\/\/doi.org\/10.1111\/hiv.12716.","journal-title":"HIV Med"},{"issue":"19","key":"1751_CR67","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.3390\/molecules24193601","volume":"24","author":"S Alven","year":"2019","unstructured":"Alven S, Aderibigbe B. Combination therapy strategies for the treatment of malaria. Molecules. 2019;24(19):3601. https:\/\/doi.org\/10.3390\/molecules24193601.","journal-title":"Molecules"},{"key":"1751_CR68","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/213595a0","volume":"213","author":"G Ceriotti","year":"1967","unstructured":"Ceriotti G. Narciclasine: an antimitotic substance from Narcissus bulbs. Nature. 1967;213:595\u20136. https:\/\/doi.org\/10.1038\/213595a0.","journal-title":"Nature"},{"issue":"10","key":"1751_CR69","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1021\/np50100a004","volume":"56","author":"GR Pettit","year":"1993","unstructured":"Pettit GR, et al. Antineoplastic agents, 256. Cell growth inhibitory isocarbostyrils from Hymenocallis. J Nat Prod. 1993;56(10):1682\u20137. https:\/\/doi.org\/10.1021\/np50100a004.","journal-title":"J Nat Prod"},{"issue":"2","key":"1751_CR70","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/med.21253","volume":"33","author":"G Van Goietsenoven","year":"2013","unstructured":"Van Goietsenoven G, et al. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers. Med Res Rev. 2013;33(2):439\u201355. https:\/\/doi.org\/10.1002\/med.21253.","journal-title":"Med Res Rev"},{"issue":"9","key":"1751_CR71","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1593\/neo.07535","volume":"9","author":"P Dumont","year":"2007","unstructured":"Dumont P, et al. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and\/or mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia. 2007;9(9):766\u201376. https:\/\/doi.org\/10.1593\/neo.07535.","journal-title":"Neoplasia"},{"issue":"4","key":"1751_CR72","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1021\/jm8013585","volume":"52","author":"L Ingrassia","year":"2009","unstructured":"Ingrassia L, et al. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. J Med Chem. 2009;52(4):1100\u201314. https:\/\/doi.org\/10.1021\/jm8013585.","journal-title":"J Med Chem"},{"issue":"7","key":"1751_CR73","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1248\/bpb.22.674","volume":"22","author":"M Mikami","year":"1999","unstructured":"Mikami M, et al. Suppressive activity of lycoricidinol (narciclasine) against cytotoxicity of neutrophil-derived calprotectin, and its suppressive effect on rat adjuvant arthritis model. Biol Pharm Bull. 1999;22(7):674\u20138. https:\/\/doi.org\/10.1248\/bpb.22.674.","journal-title":"Biol Pharm Bull"},{"issue":"31","key":"1751_CR74","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1021\/acs.jafc.5b00889","volume":"63","author":"J Kim","year":"2015","unstructured":"Kim J, et al. Effect of Lycoris chejuensis and its active components on experimental models of Alzheimer\u2019s Disease. J Agricult Food Chem. 2015;63(31):6979\u201388. https:\/\/doi.org\/10.1021\/acs.jafc.5b00889.","journal-title":"J Agricult Food Chem"},{"issue":"16","key":"1751_CR75","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1055\/s-0042-115034","volume":"82","author":"R F\u00fcrst","year":"2016","unstructured":"F\u00fcrst R. Narciclasine \u2013 an Amaryllidaceae alkaloid with potent antitumor and anti-inflammatory properties. Planta Med. 2016;82(16):1389\u201394. https:\/\/doi.org\/10.1055\/s-0042-115034.","journal-title":"Planta Med"},{"issue":"6","key":"1751_CR76","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0031-9422(00)81308-4","volume":"25","author":"JM Llabres","year":"1986","unstructured":"Llabres JM, et al. Two alkaloids from Narcissus requienii. Phytochemistry. 1986;25(6):1453\u20139. https:\/\/doi.org\/10.1016\/S0031-9422(00)81308-4.","journal-title":"Phytochemistry"},{"issue":"8","key":"1751_CR77","doi-asserted-by":"publisher","first-page":"13854","DOI":"10.3390\/molecules200813854","volume":"20","author":"JC Cedr\u00f3n","year":"2015","unstructured":"Cedr\u00f3n JC, et al. Antiproliferative and structure activity relationships of Amaryllidaceae alkaloids. Molecules. 2015;20(8):13854\u201363. https:\/\/doi.org\/10.3390\/molecules200813854.","journal-title":"Molecules"},{"issue":"14","key":"1751_CR78","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1080\/14786419.2019.1574785","volume":"34","author":"D Katoch","year":"2019","unstructured":"Katoch D, et al. Pseudolycorine N-oxide, a new N-oxide from Narcissus tazetta. Nat Prod Res. 2019;34(14):2051\u20138. https:\/\/doi.org\/10.1080\/14786419.2019.1574785.","journal-title":"Nat Prod Res"},{"issue":"8","key":"1751_CR79","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/S0031-9422(00)82560-1","volume":"24","author":"S Ghosal","year":"1985","unstructured":"Ghosal S, et al. Alkaloids of Haemanthus kalbreyeri. Phytochemistry. 1985;24(8):1825\u20138. https:\/\/doi.org\/10.1016\/S0031-9422(00)82560-1.","journal-title":"Phytochemistry"},{"issue":"8","key":"1751_CR80","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0031-9422(00)81187-5","volume":"25","author":"S Ghosal","year":"1986","unstructured":"Ghosal S, Singh SK, Srivastava RS. Alkaloids of Zephyranthes flava. Phytochemistry. 1986;25(8):1975\u20138. https:\/\/doi.org\/10.1016\/S0031-9422(00)81187-5.","journal-title":"Phytochemistry"},{"issue":"8","key":"1751_CR81","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/s0031-9422(02)00154-1","volume":"60","author":"J Labra\u00f1a","year":"2002","unstructured":"Labra\u00f1a J, et al. Alkaloids from Narcissus angustifolius subsp. transcarpathicus (Amaryllidaceae). Phytochemistry. 2002;60(8):847\u201352. https:\/\/doi.org\/10.1016\/s0031-9422(02)00154-1.","journal-title":"Phytochemistry"},{"issue":"7","key":"1751_CR82","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3987\/COM-92-6068","volume":"34","author":"M Kihara","year":"1992","unstructured":"Kihara M, et al. Incartine, a biosynthetic intermediate, from the flowers of Lycoris incarnata. Heterocycles. 1992;34(7):1299\u2013301. https:\/\/doi.org\/10.3987\/COM-92-6068.","journal-title":"Heterocycles"},{"issue":"2","key":"1751_CR83","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1248\/cpb.42.289","volume":"42","author":"M Kihara","year":"1994","unstructured":"Kihara M, et al. Isolation and structure elucidation of a novel alkaloid, incartine, a supposed biosynthetic intermediate, from flowers of Lycoris incarnata. Chem Pharm Bull. 1994;42(2):289\u201392. https:\/\/doi.org\/10.1248\/cpb.42.289.","journal-title":"Chem Pharm Bull"},{"issue":"2","key":"1751_CR84","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1248\/cpb.43.318","volume":"43","author":"M Kihara","year":"1995","unstructured":"Kihara M, Ozaki T, Kobayashi S, Shingu T. Alkaloidal constituents of Leucojum autumnale L. (Amaryllidaceae). Chem Pharm Bull. 1995;43(2):318\u201320. https:\/\/doi.org\/10.1248\/cpb.43.318.","journal-title":"Chem Pharm Bull"},{"issue":"5","key":"1751_CR85","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s12272-014-0397-2","volume":"38","author":"YY Zhu","year":"2015","unstructured":"Zhu YY, Li X, Yu HY, et al. Alkaloids from the bulbs of Lycoris longituba and their neuroprotective and acetylcholinesterase inhibitory activities. Arch Pharm Research. 2015;38(5):604\u201313. https:\/\/doi.org\/10.1007\/s12272-014-0397-2.","journal-title":"Arch Pharm Research"},{"key":"1751_CR86","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/ejoc.201001394","volume":"9","author":"GR Stephenson","year":"2011","unstructured":"Stephenson GR, Roe C, Sandoe EJ. Electrophilic C12 Building Blocks for Alkaloids: 1,1 Iterative Organoiron-Mediated Routes to (\u00b1)-Lycoramine and (\u00b1)-Maritidine. Eur J Org Chem. 2011;9:1664\u201381. https:\/\/doi.org\/10.1002\/ejoc.201001394.","journal-title":"Eur J Org Chem"},{"key":"1751_CR87","unstructured":"European Patent Office (EP2311463A1). Analogues of galanthamine and lycoramine have activity as modulators of nicotinic receptors, see: a) B. Davis, US patent US 148253, 2002; b) B. Davis, PCT Int. Appl. WO 2001043697, 2001."},{"issue":"4\u20135","key":"1751_CR88","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0928-0987(02)00185-9","volume":"17","author":"A Boobis","year":"2002","unstructured":"Boobis A, Gundert-Remy U, Kremers P, et al. In silico prediction of ADME and pharmacokinetics. Eur J Pharm Sci. 2002;17(4\u20135):183\u201393. https:\/\/doi.org\/10.1016\/s0928-0987(02)00185-9.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"1751_CR89","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.apsb.2012.10.004","volume":"2","author":"D Zhang","year":"2012","unstructured":"Zhang D, Luo G, Ding X, et al. Preclinical experimental models of drug metabolism and disposition in drug discovery and development. Acta Pharm Sinica B. 2012;2(6):549\u201361. https:\/\/doi.org\/10.1016\/j.apsb.2012.10.004.","journal-title":"Acta Pharm Sinica B"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01751-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01751-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01751-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T11:18:53Z","timestamp":1645528733000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01751-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1751"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01751-z","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"8 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}